Maligned Canadian cannabis producer CannTrust Holdings (NYSE:CTST,TSX:TRST) is facing a class-action lawsuit update.

On Monday (February 3), Henein Hutchison, speaking for a group of Ontario-based law firms, issued a statement claiming that the Ontario Superior Court of Justice has confirmed that the group can carry on with a proposed securities class action targeting the marijuana company.


The legal action is tied to CannTrust’s improper cannabis growing operations, which were discovered by regulators in July 2019. The misstep led to an eventual license suspension for the company and the damage to its reputation caused to the larger Canadian cannabis market to take a hit.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Shares of CannTrust fell in both New York and Toronto during Monday’s session. The company finished the first trading day of the week priced at US$1.04 and C$1.37.

In the pre-market trading portion of Tuesday (February 4), the company was already down an additional almost 4 percent on the New York Stock Exchange. However, just after the official start of the session, it bounced back with a 2.92 percent increase in Toronto and a 1.44 percent marginal jump in New York.

Since the original illegitimate growing discovery, which brought the dismissal of the firm’s former CEO and of its co-founder, shares of CannTrust have dropped in value dramatically by over 70 percent in both New York and Toronto.

stock chart for CannTrust Holdings

“Cases like this show the power of class actions to bring access to justice to individuals who place their savings at risk in the stock markets,” Dimitri Lascaris, a lawyer working within the group representing the investors raising the suit, said in a statement.

Marie Henein, another lawyer working on the lawsuit, said the case will be brought in front of the courts “at the earliest opportunity.”

In an emailed statement, a CannTrust spokesperson declined to comment for this story.

In its most recent mandated bi-weekly update to investors, CannTrust made no mention of the progress for the class-action suit. The company signaled it still has a cash balance of nearly C$175 million.

The legal action comes from CannTrust investors who bought shares of the company between June 1, 2018, and September 17, 2019, according to the parameters of the suit, in addition to investors who participated in a prospectus offering from the company in May 2019.

In addition to CannTrust, the suit also includes the underwriters of the CannTrust offering: Merrill Lynch Canada, Citigroup Global Markets Canada, Credit Suisse Securities (Canada), RBC Dominion Securities, Jefferies Securities and Canaccord Genuity.

The raise was designed to secure CannTrust with US$170 million in gross proceeds thanks to the sale of just over 5.4 million shares.

Tax audit and advisory firm KPMG is also included as a defendant in this case, given its role as CannTrust’s auditor.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less